While biotech stocks as a whole remain under pressure from interest rate concerns, today’s article highlights three promising small-cap biotech stocks in the neurology space… Read More »3 Promising Small-Cap Biotech Neurology Stocks
Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies… Read More »2 Potential Biotech Doublers
“Remember, no other sector sees stocks move 50% or even more than 100% in a day on a takeover announcement,” notes the author of today’s… Read More »How To Choose Which Biotech Stocks To Pull The Trigger On
As biotech stocks experience a broad correction, the analyst cited in today’s article sees “a number of compelling values” in the space. In particular, he… Read More »Looking For Wins In The Biotech Space
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street… Read More »Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management… Read More »These 3 Struggling Biotechs Could Experience Spring Bumps
What are the top biotech stocks for the second quarter with the best value? What about the top biotech stocks for Q2 with the fastest… Read More »The Top Value, Growth And Momentum Biotech Stocks For Q2
As a manufacturer of COVID-19 tests – and the top provider of COVID-19 testing in California – the company featured in today’s article has seen… Read More »Is This COVID-19 Test Manufacturer’s Spectacular Growth Story Nearing Its End – Or Entering The Next Chapter?
With a potential treatment for Alzheimer’s disease, a deal to co-develop a proven-effective COVID-19 vaccine for the U.S. market, and a platform of red-blood-cell-based cancer… Read More »Contraindicated: Why These 3 Biotech Stocks With Massive Gains Could Be Toxic For Portfolios